Rising Leaders 2025: Amir Hefni Puts Optimism Into Action At Resolution Therapeutics

In Vivo Rising Leader Amir Hefni, CEO of Resolution Therapeutics, discusses the company's advancements in macrophage cell therapies for inflammatory and fibrotic diseases, and his transition from big pharma to biotech leadership.

(Shutterstock)

More from Rising Leaders

More from C-Suite Speaks